Curcumin Improves Silica Induced Lung Fibrosis by Targeting TLR4-NLRP3 Inflammasome and TGF-β Inhibition in Mice Model.
- 1Department of Zoology, MMV, Banaras Hindu University, Varanasi, India.
- 2Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Abstract
Silicosis, a progressive occupational lung disease, caused by inhalation of crystalline silica particles, leads to chronic inflammation and pulmonary fibrosis. Increasing evidence suggests that activation of the TLR4/NF-κB signaling pathway and NLRP3 inflammasome plays a crucial role in silica-induced lung injury. This study was undertaken to investigate protective effects of curcumin against silica-induced pulmonary inflammation and fibrosis where its efficacy was compared with dexamethasone. For inducing silicosis, mice experienced silica exposure for 35 days, followed by intranasal curcumin administration. The study evaluated inflammatory responses, macrophage polarization, fibrotic alterations, and the expression of key mediators, including TLR4, NF-κB, NLRP3, ASC, caspase-1, IL-1β, TNF-α, IL-6, IL-18, TGF-β, and FN-1. Curcumin significantly reduced inflammatory cytokine expression, suppressed NLRP3 inflammasome activation, and promoted macrophage polarization toward the anti-inflammatory M2 phenotype. In addition, curcumin attenuated fibrosis by decreasing TGF-β and FN-1 expression, collagen deposition, and extracellular matrix accumulation. Histopathological findings confirmed reduced alveolar damage, silicotic nodules, goblet cell hyperplasia, mucus hypersecretion, and pulmonary fibrosis in curcumin treatment groups. This study established alleviation of silica-induced pulmonary inflammation and fibrosis by inhibiting TLR4/NF-κB and TGF-β signaling, suppressing NLRP3 inflammasome activation. It highlights the potential clinical significance of curcumin as a promising therapeutic agent in the management of silicosis and progressive lung fibrosis.
Related
- NLRP3 inflammasome-driven inflammation as a cause of atrial fibrillation: potential synergistic inhibition of the NLRP3 via upstream magnesium repletion and targeting NLRP3 with a downstream inhibitor
- Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis
- Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
- Targeting the NLRP3 inflammasome in immune cells: A new frontier in autoimmune disease research
- CDK4/6 Inhibitors and Curcumin Synergistically Suppress HER2- Breast Cancer via Lethal ROS and Inhibition of Metastasis.
BibTeX
@article{kumari2026curcumin,
title = {{Curcumin Improves Silica Induced Lung Fibrosis by Targeting TLR4-NLRP3 Inflammasome and TGF-β Inhibition in Mice Model.}},
author = {Sneha Kumari and Payal Singh and D Dash and Rashmi Singh},
journal = {Journal of biochemical and molecular toxicology},
year = {2026},
month = oct,
doi = {10.1002/jbt.71116},
url = {https://europepmc.org/article/MED/42852656},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Curcumin Improves Silica Induced Lung Fibrosis by Targeting TLR4-NLRP3 Inflammasome and TGF-β Inhibition in Mice Model.
AU - Sneha Kumari
AU - Payal Singh
AU - D Dash
AU - Rashmi Singh
PY - 2026
DA - 2026/10/01
JO - Journal of biochemical and molecular toxicology
DO - 10.1002/jbt.71116
UR - https://europepmc.org/article/MED/42852656
AB - Silicosis, a progressive occupational lung disease, caused by inhalation of crystalline silica particles, leads to chronic inflammation and pulmonary fibrosis. Increasing evidence suggests that activation of the TLR4/NF-κB signaling pathway and NLRP3 inflammasome plays a crucial role in silica-induced lung injury. This study was undertaken to investigate protective effects of curcumin against silica-induced pulmonary inflammation and fibrosis where its efficacy was compared with dexamethasone. For inducing silicosis, mice experienced silica exposure for 35 days, followed by intranasal curcumin administration. The study evaluated inflammatory responses, macrophage polarization, fibrotic alterations, and the expression of key mediators, including TLR4, NF-κB, NLRP3, ASC, caspase-1, IL-1β, TNF-α, IL-6, IL-18, TGF-β, and FN-1. Curcumin significantly reduced inflammatory cytokine expression, suppressed NLRP3 inflammasome activation, and promoted macrophage polarization toward the anti-inflammatory M2 phenotype. In addition, curcumin attenuated fibrosis by decreasing TGF-β and FN-1 expression, collagen deposition, and extracellular matrix accumulation. Histopathological findings confirmed reduced alveolar damage, silicotic nodules, goblet cell hyperplasia, mucus hypersecretion, and pulmonary fibrosis in curcumin treatment groups. This study established alleviation of silica-induced pulmonary inflammation and fibrosis by inhibiting TLR4/NF-κB and TGF-β signaling, suppressing NLRP3 inflammasome activation. It highlights the potential clinical significance of curcumin as a promising therapeutic agent in the management of silicosis and progressive lung fibrosis.
SN - 1095-6670
SN - 1099-0461
ER -